EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.14.13.161 | clotrimazole | 84% inhibition at 0.05 mM | Salvia officinalis | |
1.14.13.161 | CO | 73% inhibition at CO:O2 ratio of 9:1, activity is partially restored by blue light | Salvia officinalis |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.14.13.161 | membrane | light membrane fraction | Salvia officinalis | 16020 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.13.161 | Salvia officinalis | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.14.13.161 | cell suspension culture | - |
Salvia officinalis | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.13.161 | (+)-camphor + NADPH + H+ + O2 | - |
Salvia officinalis | (+)-6-exo-hydroxycamphor + NADP+ + H2O | - |
? |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.14.13.161 | 7 | - |
- |
Salvia officinalis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.14.13.161 | cytochrome P450 | enzyme is a cytochrome P450-dependent monooxygenase | Salvia officinalis | |
1.14.13.161 | NADPH | absolute requirement for NADPH and O2 | Salvia officinalis |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.14.13.161 | physiological function | pathway for camphor degradation follows the oxidative ring opening sequence from (+)-camphor to 6-hydroxycamphor, 6-oxocamphor, alpha-campholonic acid, and 2-hydroxy-alpha-campholonic acid. The catabolism of camphor via 1,2-campholide is a minor degradative pathway | Salvia officinalis |